Literature DB >> 30279466

Early (<4 Weeks) Versus Standard (≥ 4 Weeks) Endoscopically Centered Step-Up Interventions for Necrotizing Pancreatitis.

Guru Trikudanathan1, Pierre Tawfik1, Stuart K Amateau1, Satish Munigala1, Mustafa Arain1, Rajeev Attam1, Gregory Beilman1, Siobhan Flanagan1, Martin L Freeman1, Shawn Mallery1.   

Abstract

OBJECTIVES: Current guidelines for necrotizing pancreatitis (NP) recommend delay in drainage ± necrosectomy until 4 or more weeks after initial presentation to allow collections to wall off. However, evidence of infection with clinical deterioration despite maximum support may mandate earlier (<4 weeks) intervention. There are concerns, but scant data regarding risk of complications and outcomes with early endoscopic intervention. Our aim was to compare the results of an endoscopic centered step-up approach to NP when initiated before versus 4 or more weeks.
METHODS: All patients undergoing intervention for NP were managed using an endoscopically centered step-up approach, with transluminal drainage whenever feasible, ±necrosectomy, and/or percutaneous catheter drainage as needed, with surgery only for failures. Interventions were categorized as early or standard based on timing of intervention (<4 weeks or ≥ 4 weeks from onset of pancreatitis). Demographic data, indications and timing for interventions, number and type of intervention, mortality and morbidity (length of stay in hospital and ICU) and complications were compared.
RESULTS: Of 305 patients with collections associated with NP, 193 (63%) (median age-52 years) required intervention, performed by a step-up approach. Of the 193 patients, 76 patients underwent early and 117 patients standard intervention. 144 (75%) interventions included endoscopic drainage ± necrosectomy. As compared with standard intervention, early intervention was more often performed for infection (91% vs. 39%, p < 0.05), more associated with acute kidney injury (43% vs. 32%, p = 0.09), respiratory failure (41% vs. 22%, p = 0.005), and shock (13% vs. 4%, p < 0.05). Organ failure improved significantly after intervention in both groups. There was a significant difference in mortality (13% vs. 4%, p = 0.02) and need for rescue open necrosectomy (7% vs. 1%, p = 0.03) between groups. Patients undergoing early intervention had increased median hospital (37 days vs. 26 days, p = 0.01) and ICU stay (median 2.5 days vs. 0 days, p = 0.001). There was no difference in complications.
CONCLUSIONS: When using an endoscopically centered step-up strategy in necrotizing pancreatitis, early (<4 weeks) interventions were more often performed for infection and organ failure, with no increase in complications, similar improvement in organ failure, slightly increased need for surgery, and relatively low mortality. Early endoscopic drainage ± necrosectomy should be considered when there is a strong indication for intervention.

Entities:  

Mesh:

Year:  2018        PMID: 30279466     DOI: 10.1038/s41395-018-0232-3

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

1.  Percutaneous Endoscopic Necrosectomy (PEN): Is the PEN Mightier Than the VARD?

Authors:  Guru Trikudanathan
Journal:  Dig Dis Sci       Date:  2020-02       Impact factor: 3.199

2.  Percutaneous Endoscopic Step-Up Therapy Is an Effective Minimally Invasive Approach for Infected Necrotizing Pancreatitis.

Authors:  Saransh Jain; Rajesh Padhan; Sawan Bopanna; Sushil Kumar Jain; Rajan Dhingra; Nihar Ranjan Dash; Kumble Seetharama Madhusudan; Shivanand Ramachandra Gamanagatti; Peush Sahni; Pramod Kumar Garg
Journal:  Dig Dis Sci       Date:  2019-06-11       Impact factor: 3.199

3.  Effectiveness of digestive endoscopy and surgery in the treatment of necrotizing pancreatitis: a meta-analysis and systematic review.

Authors:  Peng Tang; Qinqing Zha; Lihua Zhou; Qiulian Yang; Mingfeng He; Shaomin Zhu; Yan Liu
Journal:  Gland Surg       Date:  2021-09

4.  Safety and clinical outcomes of early dual modality drainage (< 28 days) compared to later drainage of pancreatic necrotic fluid collections: a propensity score-matched study.

Authors:  Shivanand Bomman; David Sanders; David Coy; Danielle La Selva; Quincy Pham; Troy Zehr; Joanna Law; Michael Larsen; Shayan Irani; Richard A Kozarek; Andrew Ross; Rajesh Krishnamoorthi
Journal:  Surg Endosc       Date:  2022-08-29       Impact factor: 3.453

Review 5.  Drainage of pancreatic fluid collections in acute pancreatitis: A comprehensive overview.

Authors:  Akash Bansal; Pankaj Gupta; Anupam K Singh; Jimil Shah; Jayanta Samanta; Harshal S Mandavdhare; Vishal Sharma; Saroj Kant Sinha; Usha Dutta; Manavjit Singh Sandhu; Rakesh Kochhar
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

Review 6.  Percutaneous biopsy and drainage of the pancreas.

Authors:  Virginia Planz; Samuel J Galgano
Journal:  Abdom Radiol (NY)       Date:  2021-08-19

7.  Endoscopic ultrasound-guided transmural drainage of post-traumatic pancreatic fluid collections.

Authors:  Surinder Singh Rana; Ravi Sharma; Lovneet Dhalaria; Rajesh Gupta
Journal:  Ann Gastroenterol       Date:  2021-02-26

8.  Open Pancreatic Debridement in Necrotizing Pancreatitis.

Authors:  Thomas K Maatman; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

9.  Comparison of endoscopic versus percutaneous drainage of symptomatic pancreatic necrosis in the early (< 4 weeks) phase of illness.

Authors:  Surinder Singh Rana; Suhang Verma; Mandeep Kang; Ujjwal Gorsi; Ravi Sharma; Rajesh Gupta
Journal:  Endosc Ultrasound       Date:  2020 Nov-Dec       Impact factor: 5.628

10.  Outcomes in Endoscopic and Operative Transgastric Pancreatic Debridement.

Authors:  Thomas K Maatman; Sean P McGuire; Katelyn F Flick; Mackenzie K Madison; Mohammad A Al-Haddad; Benjamin L Bick; Eugene P Ceppa; John M DeWitt; Jeffrey J Easler; Evan L Fogel; Mark A Gromski; Michael G House; Glen A Lehman; Attila Nakeeb; C Max Schmidt; Stuart Sherman; James L Watkins; Nicholas J Zyromski
Journal:  Ann Surg       Date:  2021-09-01       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.